JP2022513437A5 - - Google Patents
Info
- Publication number
- JP2022513437A5 JP2022513437A5 JP2021529785A JP2021529785A JP2022513437A5 JP 2022513437 A5 JP2022513437 A5 JP 2022513437A5 JP 2021529785 A JP2021529785 A JP 2021529785A JP 2021529785 A JP2021529785 A JP 2021529785A JP 2022513437 A5 JP2022513437 A5 JP 2022513437A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antigen
- binding fragment
- monoclonal antibody
- antibody
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862772235P | 2018-11-28 | 2018-11-28 | |
| US62/772,235 | 2018-11-28 | ||
| PCT/US2019/063729 WO2020113084A1 (en) | 2018-11-28 | 2019-11-27 | Therapeutic factor xii antibody |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022513437A JP2022513437A (ja) | 2022-02-08 |
| JPWO2020113084A5 JPWO2020113084A5 (https=) | 2022-09-29 |
| JP2022513437A5 true JP2022513437A5 (https=) | 2022-09-29 |
| JP7478149B2 JP7478149B2 (ja) | 2024-05-02 |
Family
ID=69024611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021529785A Active JP7478149B2 (ja) | 2018-11-28 | 2019-11-27 | 治療用第ｘｉｉ因子抗体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12134657B2 (https=) |
| EP (1) | EP3886982A1 (https=) |
| JP (1) | JP7478149B2 (https=) |
| CN (1) | CN113423465B (https=) |
| WO (1) | WO2020113084A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023531315A (ja) * | 2020-07-03 | 2023-07-21 | シーエスエル・イノベーション・プロプライエタリー・リミテッド | 第ｘｉｉ因子抗原結合タンパク質の高濃度製剤 |
| CN116265945B (zh) * | 2022-01-05 | 2025-12-09 | 上海迈晋生物医药科技有限公司 | 抗凝血药物的生物学活性检测方法 |
| EP4729546A1 (en) * | 2023-06-16 | 2026-04-22 | Jiangsu BioJeTay Biotechnology Co., Ltd. | Antibody specifically recognizing factor xiia and use thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4957939A (en) | 1981-07-24 | 1990-09-18 | Schering Aktiengesellschaft | Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging |
| US4472509A (en) | 1982-06-07 | 1984-09-18 | Gansow Otto A | Metal chelate conjugated monoclonal antibodies |
| US4938948A (en) | 1985-10-07 | 1990-07-03 | Cetus Corporation | Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies |
| JPH049249A (ja) | 1990-04-27 | 1992-01-14 | Kusuda:Kk | 塗型剤吹き付け機 |
| WO2003013423A2 (en) | 2001-08-05 | 2003-02-20 | Gvg, Inc. | Antithrombotic agent |
| CA2591786C (en) | 2004-12-23 | 2013-07-16 | Bernhard Nieswandt | Prevention of thrombus formation and/or stabilization |
| ES3005912T3 (en) * | 2011-07-22 | 2025-03-17 | Csl Behring Gmbh | Inhibitory anti-factor xii/xiia monoclonal antibodies and their uses |
| CN202179824U (zh) | 2011-07-22 | 2012-04-04 | 北京美亚视景创恒科技有限公司 | 数字健身设备集群系统 |
| WO2014089493A1 (en) | 2012-12-07 | 2014-06-12 | Vanderbilt University | Antibodies against factor xii and uses thereof |
| BR112016029624A2 (pt) * | 2014-06-18 | 2017-10-24 | Csl Behring Gmbh | terapia usando um inibidor do fator xii em um distúrbio neurotraumático |
-
2019
- 2019-11-27 JP JP2021529785A patent/JP7478149B2/ja active Active
- 2019-11-27 US US17/297,967 patent/US12134657B2/en active Active
- 2019-11-27 WO PCT/US2019/063729 patent/WO2020113084A1/en not_active Ceased
- 2019-11-27 CN CN201980090647.9A patent/CN113423465B/zh active Active
- 2019-11-27 EP EP19828384.8A patent/EP3886982A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2595091T3 (es) | Composiciones farmacéuticas con resistencia a CEA soluble | |
| JP2023002615A5 (https=) | ||
| WO2019024911A1 (zh) | B7h3抗体-药物偶联物及其医药用途 | |
| MX2010013236A (es) | Inmunoglobulinas de dominio variable doble y usos de las mismas. | |
| MX2010011955A (es) | Inmunoglobulinas de dominio variable doble y usos de las mismas. | |
| JP2018531219A (ja) | Ｐｄ−ｌ１抗体 | |
| JP2018531219A6 (ja) | Ｐｄ−ｌ１抗体 | |
| TW202126693A (zh) | 標靶bcma的抗體、雙專一性抗體及其用途 | |
| JP2021510736A5 (https=) | ||
| JPWO2019246514A5 (https=) | ||
| RU2009123409A (ru) | Новые антипролиферативные антитела | |
| JP2020522488A5 (https=) | ||
| JP2022513437A5 (https=) | ||
| JP2024514109A (ja) | 抗ｃｎｔｎ４抗体及びその使用 | |
| CN117279950B (zh) | 一种靶向il-18bp的抗体及其应用 | |
| JP2018528759A5 (https=) | ||
| CN114591434A (zh) | 抗Siglec15抗体及其制备方法和用途 | |
| JP2019510474A (ja) | トロンビン抗体、その抗原結合フラグメント及び医薬用途 | |
| JP2026027248A (ja) | 抗原結合分子およびその使用 | |
| JPWO2022159984A5 (https=) | ||
| JPWO2020113084A5 (https=) | ||
| JPWO2020023644A5 (https=) | ||
| US20250161441A1 (en) | Medicine comprising combination of anti-mutant-calr antibody and another drug | |
| CN120187752A (zh) | 人源化的l1cam抗体药物偶联物 | |
| JPWO2023061505A5 (https=) |